Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome.
about
Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Bortezomib Warhead-Switch Conf ...... vity against Human Proteasome.
@ast
Bortezomib Warhead-Switch Conf ...... vity against Human Proteasome.
@en
type
label
Bortezomib Warhead-Switch Conf ...... vity against Human Proteasome.
@ast
Bortezomib Warhead-Switch Conf ...... vity against Human Proteasome.
@en
prefLabel
Bortezomib Warhead-Switch Conf ...... vity against Human Proteasome.
@ast
Bortezomib Warhead-Switch Conf ...... vity against Human Proteasome.
@en
P2093
P2860
P356
P1476
Bortezomib Warhead-Switch Conf ...... ivity against Human Proteasome
@en
P2093
Brian W Dymock
Sridhar Santhanakrishnan
Wilfried Moreira
P2860
P356
10.3389/FMICB.2017.00746
P50
P577
2017-04-27T00:00:00Z